Diversity in clinical trials matters for drug safety and efficacy—and for future medical advancements. Clinical trial ...

The emergence of AI and biosensors offers a chance to address inefficiencies in drug development.

In today’s ACT Brief, we cover how AI is being deployed to optimize global trial design, why ESG performance is emerging as a core vendor qualification signal, and how sites are becoming more ...

Forbes contributors publish independent expert analyses and insights. I write about the application of AI & Big Data to innovation and prediction. Feb 22, 2024, 03:42am EST Clinical trials are ...

Raja Shankar, VP of machine learning at IQVIA, discusses which AI capabilities sponsors are most likely to adopt first to ...

BOSTON--(BUSINESS WIRE)--Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and ...

Furthermore, increasing complexity in cancer clinical trial design has led to challenges such as protocol deviations, slow enrollment leading to lengthened durations of trial, and escalating costs. By ...

A Swiss startup called Risklick has launched artificial intelligence software for clinical trials that the company claims can reduce development time and costs by as much as 35%, according to an April ...

Even when promising clinical trials exist, and the FDA allows expanded access, rare disease patients like my granddaughter ...

The Food and Drug Administration on Wednesday defended its rejection of Moderna’s mRNA-based flu vaccine application, saying the company’s clinical trial design put patients at risk ...